| P2093 | author name string | Agustín Codina Puiggrós | |
| | Carlos Cervera Radigales | |
| P2860 | cites work | Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies | Q28140367 |
| | Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome | Q28297319 |
| | Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome | Q31810977 |
| | Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections | Q34746556 |
| | Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom | Q35450412 |
| | Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody | Q35452364 |
| | Anti-GQ1b IgG antibody syndrome: clinical and immunological range | Q35572316 |
| | Epidemiological study of Guillain-Barré syndrome in south east England | Q36317618 |
| | Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides | Q36900370 |
| | Epidemiologic and clinical features of Campylobacter jejuni infections | Q41660326 |
| | Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome | Q41838846 |
| | Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome | Q42551135 |
| | Indicators of rapid clinical recovery in Guillain-Barré syndrome | Q43071270 |
| | Preceding infections, immune factors, and outcome in Guillain-Barré syndrome | Q43556824 |
| | Overlapping Guillain-Barré syndrome and Bickerstaff's brainstem encephalitis associated with anti-GQ1b IgG antibody after herpes simplex virus infection | Q45736582 |
| | IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome | Q47671725 |
| | Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes | Q48881651 |
| | Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody | Q56772330 |
| | Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan | Q56772352 |
| | Anticuerpos anti-GQ1b: utilidad de su determinación en el diagnóstico del síndrome de Miller-Fisher | Q59876095 |
| | The axon in Guillain-Barré syndrome: immune target or innocent bystander? | Q70928201 |
| | Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody | Q71053685 |
| | Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study | Q73405045 |
| | Acute bilateral ophthalmoplegia with raised anti-GQ1b antibodies | Q73714740 |
| | Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome | Q73766463 |
| | Clinical features and prognosis of Miller Fisher syndrome | Q73800930 |
| | Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome | Q73979986 |
| | Preserved tendon reflexes in Campylobacter neuropathy | Q74452590 |
| | Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy | Q74485703 |
| | Guillain-Barré syndrome | Q77326744 |
| | Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody | Q77690608 |
| | Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia | Q78032841 |
| P433 | issue | 4 | |
| P921 | main subject | Guillain–Barré syndrome | Q205214 |
| P304 | page(s) | 142-145 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Medicina clínica | Q26854009 |
| P1476 | title | [Guillain-Barre syndrome] | |
| P478 | volume | 118 | |